|
Agenda: International Pharma Congress: Day I
Monday, May 14, 2012
|
|
10:00 a.m. |
Registration Opens
|
|
11:00 a.m. |
Exhibit Hall Opens; Welcome Box Luncheon served in Exhibit Hall
|
|
12:30 p.m. |
Announcement of the Signature of New Hungarian Pharmaceutical Code of Ethics (in Hungarian)
|
|
DAY I: OPENING PLENARY SESSION
|
1:00 p.m.
 |
Welcome and Introductions
Roeland Van Aelst
Vice President EMEA and Canada, Office of Health Care Compliance and Privacy, Johnson & Johnson, Brussels, Belgium (Co chair)
|
1:15 p.m.
 |
International Pharma Congress Vision and Overview
Ann Beasley Bacon
Global Compliance Officer, Novartis Pharma AG, Basel, Switzerland (Co chair)
|
 |
Kelly B. Freeman, PhD
Ethics and Compliance Officer, Eli Lilly and Company, Indianapolis, IN, USA (Co chair)
|
 |
Dominique Laymand, Esq.
Vice President Compliance and Ethics EMEA (Europe, Middle-East, Africa, Russia and Turkey), Bristol-Myers Squibb, Paris, France, (Co chair)
Presentation Material (Acrobat)
|
|
|
Roeland Van Aelst
Vice President EMEA and Canada, Office of Health Care Compliance and Privacy, Johnson & Johnson, Brussels, Belgium (Co chair)
|
1:30 p.m.
 |
Gabor Danielfy Memorial Keynote Address: The Role of Global Compliance in the Pharmaceutical Industry
Christopher A. Viehbacher
Chief Executive Officer, Sanofi, Chairman, Genzyme, Paris, France
|
2:00 p.m.
 |
EU Annual Compliance and EFPIA Compliance Initiatives Update
Richard Bergström
Director General, European Federation of the Pharmaceutical Industries and Associations (EFPIA); Former Director General, LIF Sweden, Brussels, Belgium
Presentation Material (Acrobat)
|
 |
Discussion Facilitators:
Sue Egan
Director and Principal Consultant, Sue Egan Associates; Editor, Life Science Compliance; Former Vice President Compliance, AstraZeneca, Great Missenden, Buckinghamshire, UK
|
 |
Dave O'Shaughnessy
Vice President, Global Compliance, Astra- Zeneca, Former Vice President and Compliance Officer, Emerging Markets and Asia Pacific, GlaxoSmithKline, London, UK
|
3:00 p.m.
 |
CEE Annual Compliance Update
Madina Torchinova, Esq.
Regional Compliance Officer CEE, Sandoz; Former Director Legal and Regulatory Affairs, Association of International Pharmaceutical Manufacturers (AIPM), Russia, Munich, Germany
Presentation Material (Acrobat)
|
|
3:30 p.m. |
Break
|
4:00 p.m.
 |
MEA Annual Compliance Update
Joe Henein
President and Chief Executive Officer, NewBridge Pharmaceuticals; Former Regional Managing Director, Middle East and North Africa, Wyeth Pharmaceuticals, Dubai, United Arab Emirates
Presentation Material (Acrobat)
|
4:30 p.m.
 |
Regional Anti-Bribery Developments Roundtable
Ted Acosta, Esq.
Principal, Ernst & Young LLP; Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY, USA and Paris, France
|
4:50 p.m.
 |
US FCPA Update
Michael J.J. Brueck, LLM, Ph.D. (Dr. iur.)
Counsel, Sidley Austin LLP, Professor of Law, German Graduate School of Management and Law, Heilbronn, Germany, Frankfurt, Germany
|
 |
Rosanne M. Kay, Esq.
Partner, Reed Smith, London, UK
|
|
|
Ted Acosta, Esq.
Principal, Ernst & Young LLP; Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY, USA and Paris, France (Moderator)
|
5:20 p.m.
 |
UK Bribery Act (audio presentation)
Joseph B. Tompkins, Jr.
Partner, Sidley Austin LLP; Former Deputy Chief of the Fraud Section, Criminal Division, United States Department of Justice, Washington, DC, USA (Moderator)
(Presented for Jane de Lozey and Raymond Emson)
Presentation Material (Acrobat)
|
|
6:00 p.m. |
Adjournment and Networking Reception
|
|
|
